The neuromuscular differential diagnosis of joint hypermobility
暂无分享,去创建一个
[1] M. Goumans,et al. Mutations in a TGF-β Ligand, TGFB3, Cause Syndromic Aortic Aneurysms and Dissections , 2015, Journal of the American College of Cardiology.
[2] M. Castori,et al. Neurological manifestations of Ehlers-Danlos syndrome(s): A review , 2014, Iranian journal of neurology.
[3] M. Lek,et al. G.P.35 Analysis of a large patient cohort with recessive truncating TTN mutations reveals novel clinical features and a diverse range of muscle pathologies , 2014, Neuromuscular Disorders.
[4] C. Bönnemann,et al. Molecules in Focus: Collagen XII: Protecting bone and muscle integrity by organizing collagen fibrils , 2014 .
[5] G. Sobey. Ehlers–Danlos syndrome: how to diagnose and when to perform genetic tests , 2014, Archives of Disease in Childhood.
[6] K. Bushby,et al. Novel Mutations Widen the Phenotypic Spectrum of Slow Skeletal/β‐Cardiac Myosin (MYH7) Distal Myopathy , 2014, Human mutation.
[7] P. Byers,et al. FKBP14‐related Ehlers‐Danlos syndrome: Expansion of the phenotype to include vascular complications , 2014, American Journal of Medical Genetics. Part A.
[8] E. Malfatti,et al. Autosomal dominant eccentric core disease caused by a heterozygous mutation in the MYH7 gene , 2014, Journal of Neurology, Neurosurgery & Psychiatry.
[9] M. Devoto,et al. Recessive and dominant mutations in COL12A1 cause a novel EDS/myopathy overlap syndrome in humans and mice. , 2014, Human molecular genetics.
[10] K. Bushby,et al. Mutations in the collagen XII gene define a new form of extracellular matrix-related myopathy. , 2014, Human molecular genetics.
[11] H. Dietz,et al. Loeys–Dietz syndrome: a primer for diagnosis and management , 2014, Genetics in Medicine.
[12] N. Hübner,et al. Recessive TTN truncating mutations define novel forms of core myopathy with heart disease. , 2014, Human molecular genetics.
[13] Ching H. Wang,et al. Diagnostic approach to the congenital muscular dystrophies , 2014, Neuromuscular Disorders.
[14] E. Bertini,et al. Natural history of pulmonary function in collagen VI-related myopathies. , 2013, Brain : a journal of neurology.
[15] R. Weiss,et al. Position of Glycine Substitutions in the Triple Helix of COL6A1, COL6A2, and COL6A3 is Correlated with Severity and Mode of Inheritance in Collagen VI Myopathies , 2013, Human mutation.
[16] A. Janecke,et al. Loss of dermatan sulfate epimerase (DSE) function results in musculocontractural Ehlers-Danlos syndrome. , 2013, Human molecular genetics.
[17] J. Schalkwijk,et al. Compound heterozygous mutations of the TNXB gene cause primary myopathy , 2013, Neuromuscular Disorders.
[18] F. Muntoni,et al. RyR1 Deficiency in Congenital Myopathies Disrupts Excitation–Contraction Coupling , 2013, Human mutation.
[19] L. Wilkins. Severe congenital RYR1-associated myopathy: The expanding clinicopathologic and genetic spectrum , 2013, Neurology.
[20] G. Mortier,et al. Helical mutations in type I collagen that affect the processing of the amino-propeptide result in an Osteogenesis Imperfecta/Ehlers-Danlos Syndrome overlap syndrome , 2013, Orphanet Journal of Rare Diseases.
[21] R. Finkel,et al. Severe congenital RYR1-associated myopathy , 2013, Neurology.
[22] Mark R. Morris,et al. Perlman Syndrome: Overgrowth, Wilms Tumor Predisposition and DIS3L2. , 2013, American Journal of Medical Genetics. Part C, Seminars in Medical Genetics.
[23] F. Muntoni,et al. Congenital myopathies – Clinical features and frequency of individual subtypes diagnosed over a 5-year period in the United Kingdom , 2013, Neuromuscular Disorders.
[24] N. Voermans. Corrigendum to: “Myopathy in a 20‐Year‐Old Female Patient With D4ST‐1 Deficient Ehlers‐Danlos Syndrome Due to a Homozygous CHST14 Mutation, Am J Med Genet A. 2012 Apr; 158A(4):850–855” , 2013 .
[25] S. Apte,et al. The biology of the extracellular matrix: novel insights , 2013, Current opinion in rheumatology.
[26] A. de Haan,et al. Neuromuscular properties of the thigh muscles in patients with ehlers–danlos syndrome , 2013, Muscle & nerve.
[27] F. Muntoni,et al. Mutations in MYH7 cause Multi-minicore Disease (MmD) with variable cardiac involvement , 2012, Neuromuscular Disorders.
[28] C. Bönnemann,et al. Spontaneous keloid formation in patients with Bethlem myopathy , 2012, Neurology.
[29] E. Fishman,et al. Loss-of-function mutations in TGFB2 cause a syndromic presentation of thoracic aortic aneurysm , 2012, Nature Genetics.
[30] K. Bushby,et al. Clinical and genetic findings in a large cohort of patients with ryanodine receptor 1 gene‐associated myopathies , 2012, Human mutation.
[31] P. Guicheney,et al. Selenoprotein N in skeletal muscle: from diseases to function , 2012, Journal of Molecular Medicine.
[32] T. Irving,et al. Titin-based stiffening of muscle fibers in Ehlers-Danlos Syndrome. , 2012, Journal of applied physiology.
[33] N. van Alfen,et al. Myopathy in a 20‐year‐old female patient with D4ST‐1 deficient Ehlers‐Danlos syndrome due to a homozygous CHST14 mutation , 2012, American journal of medical genetics. Part A.
[34] F. Muntoni,et al. Mutations in FKBP14 cause a variant of Ehlers-Danlos syndrome with progressive kyphoscoliosis, myopathy, and hearing loss. , 2012, American journal of human genetics.
[35] I. Higuchi. [Collagen VI-related muscle disorders]. , 2011, Brain and nerve = Shinkei kenkyu no shinpo.
[36] M. Pane,et al. Muscle magnetic resonance imaging in congenital myopathies due to ryanodine receptor type 1 gene mutations. , 2011, Archives of neurology.
[37] Y. Fukushima,et al. Delineation of dermatan 4‐O‐sulfotransferase 1 deficient Ehlers–Danlos syndrome: Observation of two additional patients and comprehensive review of 20 reported patients , 2011, American journal of medical genetics. Part A.
[38] C. Bönnemann. The collagen VI-related myopathies: muscle meets its matrix , 2011, Nature Reviews Neurology.
[39] A. Krol,et al. Satellite cell loss and impaired muscle regeneration in selenoprotein N deficiency. , 2011, Human Molecular Genetics.
[40] G. Vriend,et al. Mutations in SMAD3 cause a syndromic form of aortic aneurysms and dissections with early-onset osteoarthritis , 2011, Nature Genetics.
[41] Straub,et al. RYR1 mutations are a common cause of congenital myopathies with central nuclei , 2010, Annals of neurology.
[42] N. Maraldi,et al. Autophagy is defective in collagen VI muscular dystrophies, and its reactivation rescues myofiber degeneration , 2010, Nature Medicine.
[43] P. Huijing,et al. Muscle characteristics and altered myofascial force transmission in tenascin-X-deficient mice, a mouse model of Ehlers-Danlos syndrome. , 2010, Journal of applied physiology.
[44] H. Dietz,et al. Musculoskeletal findings of Loeys-Dietz syndrome. , 2010, The Journal of bone and joint surgery. American volume.
[45] Y. Fukushima,et al. Loss‐of‐function mutations of CHST14 in a new type of Ehlers‐Danlos syndrome , 2010, Human mutation.
[46] Laurence Faivre,et al. The revised Ghent nosology for the Marfan syndrome , 2010, Journal of Medical Genetics.
[47] G. Vasco,et al. Muscle magnetic resonance imaging involvement in muscular dystrophies with rigidity of the spine , 2010, Annals of neurology.
[48] G. Utermann,et al. Loss of dermatan-4-sulfotransferase 1 function results in adducted thumb-clubfoot syndrome. , 2009, American journal of human genetics.
[49] C. Bönnemann,et al. Myopathy and polyneuropathy in an adolescent with the kyphoscoliotic type of Ehlers–Danlos syndrome , 2009, American journal of medical genetics. Part A.
[50] A. Krol,et al. Selenoprotein N is dynamically expressed during mouse development and detected early in muscle precursors , 2009, BMC Developmental Biology.
[51] S. Pillen,et al. Neuromuscular features in Marfan syndrome , 2009, Clinical genetics.
[52] I. V. van Rooij,et al. Neuromuscular involvement in various types of Ehlers–Danlos syndrome , 2009, Annals of neurology.
[53] B. Engelen,et al. Joint hypermobility as a distinctive feature in the differential diagnosis of myopathies , 2009, Journal of Neurology.
[54] P. Huijing,et al. Clinical and molecular overlap between myopathies and inherited connective tissue diseases , 2008, Neuromuscular Disorders.
[55] P. Bonaldo,et al. Autosomal recessive myosclerosis myopathy is a collagen VI disorder , 2008, Neurology.
[56] R. Sciot,et al. Predominant fiber atrophy and fiber type disproportion in early ullrich disease , 2008, Muscle & nerve.
[57] F. Muntoni,et al. Congenital muscle disorders with cores: the ryanodine receptor calcium channel paradigm. , 2008, Current opinion in pharmacology.
[58] B. Engelen,et al. Differential diagnosis of muscular hypotonia in infants: The kyphoscoliotic type of Ehlers–Danlos syndrome (EDS VI) , 2008, Neuromuscular Disorders.
[59] B. V. van Engelen,et al. Ehlers–Danlos syndrome due to tenascin‐X deficiency: Muscle weakness and contractures support overlap with collagen VI myopathies , 2007, American journal of medical genetics. Part A.
[60] B. Engelen,et al. Reduced quantitative muscle function in tenascin-X deficient Ehlers-Danlos patients , 2007, Neuromuscular Disorders.
[61] Susan C. Brown,et al. Molecular mechanisms and phenotypic variation in RYR1-related congenital myopathies. , 2007, Brain : a journal of neurology.
[62] H. Jungbluth. Multi-minicore Disease , 2007, Orphanet journal of rare diseases.
[63] F. Muntoni,et al. Centronuclear myopathy due to a de novo dominant mutation in the skeletal muscle ryanodine receptor (RYR1) gene , 2007, Neuromuscular Disorders.
[64] Kevin B. Jones,et al. Symposium on the musculoskeletal aspects of marfan syndrome: Meeting report and state of the science , 2007, Journal of orthopaedic research : official publication of the Orthopaedic Research Society.
[65] E. Bertini,et al. Cardiac and pulmonary investigations in Bethlem myopathy. , 2006, Archives of neurology.
[66] I. Thiffault,et al. A new form of congenital muscular dystrophy with joint hyperlaxity maps to 3p23-21. , 2006, Brain : a journal of neurology.
[67] H. F. Carvalho,et al. Identification, content, and distribution of type VI collagen in bovine tendons , 2006, Cell and Tissue Research.
[68] Wolfram Kress,et al. A syndrome of altered cardiovascular, craniofacial, neurocognitive and skeletal development caused by mutations in TGFBR1 or TGFBR2 , 2005, Nature Genetics.
[69] J. Weis,et al. Homozygous microdeletion of chromosome 4q11‐q12 causes severe limb‐girdle muscular dystrophy type 2E with joint hyperlaxity and contractures , 2005, Human mutation.
[70] J. Allsop,et al. Muscle MRI in Ullrich congenital muscular dystrophy and Bethlem myopathy , 2005, Neuromuscular Disorders.
[71] Wall Me,et al. Early responses to mechanical load in tendon: role for calcium signaling, gap junctions and intercellular communication. , 2005 .
[72] G. Bydder,et al. Magnetic resonance imaging of muscle in congenital myopathies associated with RYR1 mutations , 2004, Neuromuscular Disorders.
[73] Susan C. Brown,et al. Congenital muscular dystrophy with short stature, proximal contractures and distal laxity. , 2004, Neuropediatrics.
[74] F. Hanefeld,et al. Muscle ultrasound in Bethlem myopathy. , 2003, Neuropediatrics.
[75] Ivan Stamenkovic,et al. Functional structure and composition of the extracellular matrix , 2003, The Journal of pathology.
[76] A. Malandrini,et al. Neurological presentation of Ehlers–Danlos syndrome type IV in a family with parental mosaicism , 2003, Clinical Genetics.
[77] A. Child,et al. Muscle fibrillin deficiency in Marfan’s syndrome myopathy , 2003, Journal of neurology, neurosurgery, and psychiatry.
[78] A. Superti-Furga,et al. The Ehlers‐Danlos Syndrome , 2003 .
[79] F. Muntoni,et al. Mutations of the selenoprotein N gene, which is implicated in rigid spine muscular dystrophy, cause the classical phenotype of multiminicore disease: reassessing the nosology of early-onset myopathies. , 2002, American journal of human genetics.
[80] I. Nonaka,et al. Ullrich disease: Collagen VI deficiency: EM suggests a new basis for muscular weakness , 2002, Neurology.
[81] Susan C. Brown,et al. Autosomal recessive inheritance of RYR1 mutations in a congenital myopathy with cores , 2002, Neurology.
[82] Susan C. Brown,et al. Collagen VI involvement in Ullrich syndrome: A clinical, genetic, and immunohistochemical study , 2002, Neurology.
[83] E. Bertini,et al. Bethlem myopathy (BETHLEM) 86th ENMC International Workshop, 10–11 November 2000, Naarden, The Netherlands , 2002, Neuromuscular Disorders.
[84] Nimish J. Thakore,et al. Novel mutations in collagen VI genes: Expansion of the Bethlem myopathy phenotype , 2002, Neurology.
[85] J. Schalkwijk,et al. A recessive form of the Ehlers-Danlos syndrome caused by tenascin-X deficiency. , 2001, The New England journal of medicine.
[86] F. Muntoni,et al. Mutations in SEPN1 cause congenital muscular dystrophy with spinal rigidity and restrictive respiratory syndrome , 2001, Nature Genetics.
[87] L. Lagae,et al. Classical Ehlers-Danlos syndrome caused by a mutation in type I collagen. , 2000, American journal of human genetics.
[88] P. Beighton,et al. Ehlers-Danlos syndromes: revised nosology, Villefranche, 1997. Ehlers-Danlos National Foundation (USA) and Ehlers-Danlos Support Group (UK). , 1998, American journal of medical genetics.
[89] P. Beighton,et al. Ehlers-Danlos syndromes: revised nosology, Villefranche, 1997. Ehlers-Danlos National Foundation (USA) and Ehlers-Danlos Support Group (UK). , 1998, American journal of medical genetics.
[90] S. Kügler,et al. Ehlers-Danlos syndrome type VI: lysyl hydroxylase deficiency due to a novel point mutation (W612C) , 1998, Archives of Dermatological Research.
[91] F. Baas,et al. Type VI collagen mutations in Bethlem myopathy, an autosomal dominant myopathy with contractures , 1996, Nature Genetics.
[92] W. Hu,et al. Developmental expression of fibrillin genes suggests heterogeneity of extracellular microfibrils , 1995, The Journal of cell biology.
[93] R. Grahame,et al. The Marfan syndrome: joint and skin manifestations are prevalent and correlated. , 1995, British journal of rheumatology.
[94] S. Pinnell,et al. A patient with Ehlers-Danlos syndrome type VI is a compound heterozygote for mutations in the lysyl hydroxylase gene. , 1994, Journal of Clinical Investigation.
[95] S. Pinnell,et al. Ehlers-Danlos syndromes , 2019, BMJ.
[96] A. Julià,et al. Ehlers-Danlos syndrome, clotting disorders and muscular dystrophy. , 1989, Annals of the rheumatic diseases.
[97] J. Gamble,et al. Orthopaedic aspects of central core disease. , 1988, The Journal of bone and joint surgery. American volume.
[98] T. Baxter,et al. Muscle formation in Ehlers-Danlos syndrome. , 1981, Archives of physical medicine and rehabilitation.
[99] J. Timmermans,et al. Mutations in a TGF- b Ligand, TGFB3, Cause Syndromic Aortic Aneurysms and Dissections , 2015 .
[100] K. Bushby,et al. Collagen type VI myopathies. , 2014, Advances in experimental medicine and biology.
[101] C. Bönnemann,et al. Chapter 70 – ECM-Related Myopathies and Muscular Dystrophies , 2012 .
[102] E. Olson,et al. Muscle : fundamental biology and mechanisms of disease , 2012 .
[103] F. Muntoni,et al. Core myopathies. , 2011, Seminars in Pediatric Neurology.
[104] B. Thisse,et al. Loss of selenoprotein N function causes disruption of muscle architecture in the zebrafish embryo. , 2007, Experimental Cell Research.
[105] A. Banes,et al. Early responses to mechanical load in tendon: role for calcium signaling, gap junctions and intercellular communication. , 2005, Journal of musculoskeletal & neuronal interactions.
[106] T. Godwin,et al. Congenital Muscular Dystrophy , 2015 .
[107] A. Bulbena,et al. Clinical assessment of hypermobility of joints: assembling criteria. , 1992, The Journal of rheumatology.